DB HiTek (000990): Where It Stands — 2026-09-16 Deep Dive
2026-09-16 · semiconductor · DB HiTek data page
As of 2026-09-16 (Seoul close). Live numbers on the DB HiTek data page.
| Metric | Value |
|---|---|
| Close | ₩126,000 |
| Day | +5.18% |
| 5d / 20d / 60d | +13.00% / +34.62% / -27.59% |
| 52w position | 46.2% (₩44,700–₩220,500) |
| MA20 / MA60 | ₩99,905 / ₩105,733 |
DB HiTek: Rapid Rebound Confronts Foreign Selling
DB HiTek (KRX 000990) advanced 5.18% to close at ₩126,000 on September 16, 2026, outperforming the benchmark KOSPI (+1.37%) and tech-heavy KOSDAQ (+0.44%). The single-day move extends a rapid multi-week recovery: the stock has gained 13.00% over the past 5 trading sessions and 34.62% over the past 20 sessions. This 20-day performance substantially outpaces the covered Korean semiconductor peer group, which posted a median 20-day return of +7.28%.
Despite this sprint, DB HiTek’s longer-term performance still reflects the sharp drawdown experienced over the summer. Over a 60-day horizon, the stock remains down 27.59%. At ₩126,000, DB HiTek trades at 46.2% of its wide 52-week trading range of ₩44,700 to ₩220,500.
Technically, the rally has cleared intermediate overhead resistance. The closing price sits well above both its 20-day moving average (₩99,905) and its 60-day moving average (₩105,733). The crossing of the MA60 confirms an accelerated shift in momentum following months of consolidation below six-figure levels. Flow dynamics on the day, however, reveal clear institutional and foreign divergence: domestic institutions net-bought 133,846 shares, supporting the breakout, while foreign investors offloaded a net 271,646 shares into strength.
Drivers: 8-Inch Foundry Realignment and Valuation Reset
DB HiTek operates as South Korea’s leading pure-play 200mm (8-inch) analog and mixed-signal foundry, specializing in power management integrated circuits (PMICs), BCDMOS processes, display driver ICs (DDIs), and CMOS image sensors (CIS). The recent outperformance relative to the broader domestic semi basket (+34.62% vs. +7.28% over 20 days) reflects two distinct factors:
- Rebound from Oversold Summer Depths: The 60-day decline of 27.59% reflected widespread market concerns regarding utilization softening across legacy 8-inch nodes and competitive pricing from Chinese foundries. The sharp 20-day reversal indicates that market expectations had excessively discounted fab utilization rates. As channel inventories for consumer electronics and industrial PMICs stabilized toward late Q3 2026, marginal improvements in wafer starts have triggered high-beta short-covering and institutional re-accumulation.
- Specialty Analog and Compound Semi Tailwinds: DB HiTek’s strategic transition toward high-voltage PMICs and preliminary capacity allocation for compound semiconductors (silicon carbide/SiC and gallium nitride/GaN) provides insulation against commoditized silicon pricing. The institutional accumulation of 133,846 shares reflects domestic fund positioning ahead of potential utilization inflection points in higher-margin automotive and industrial power discrete categories.
Risks and Caveats
- Foreign Outflows: Net foreign selling of 271,646 shares on a day when the stock gained over 5% points to profit-taking and structural skepticism from offshore accounts. Persistent foreign distribution could cap upside near the midpoint of the 52-week range.
- Overhead Resistance: While clearing the MA60 (₩105,733) represents a technical milestone, the stock remains more than 40% below its 52-week peak of ₩220,500. Stiff supply overhead persists from positions accumulated during earlier cyclical highs.
- Mature-Node Capacity Pressure: DB HiTek remains exposed to global 8-inch foundry dynamics. Ongoing expansion of mature-node domestic capacity in mainland China threatens blended average selling prices (ASPs) for standard PMIC and DDI runs, limiting long-term gross margin expansion unless DB HiTek accelerates its shift to proprietary, high-barrier BCDMOS nodes.
This note was produced by Chip & Cell’s data pipeline with model-assisted analysis. It is not investment advice; verify all figures against primary sources.
Not investment advice. Figures are as of publication and may contain errors — see methodology.